Nav: Home

New study underscores tuberculosis risk for working elephants

February 05, 2018

Morris Animal Foundation-funded researchers recently found approximately 17 percent of working African elephants at several Zimbabwe ecotourism facilities tested positive for tuberculosis antibodies. The findings are a red flag for researchers as infected elephants potentially can pass the disease on to humans and other species with which they come in contact, including wild elephants.

Tuberculosis is a serious disease in elephants. Most cases are caused by Mycobacterium tuberculosis, the same bacterium that causes the disease in humans. Dr. Laura Rosen and her colleagues at Colorado State University and other institutions, are evaluating tuberculosis prevention, diagnosis and antimicrobial control strategies in elephants. Their findings and recommended preventive measures recently were published in the journal Transboundary and Emerging Diseases.

"This project represents a first step in assessing the risk of tuberculosis in elephants in Africa," said Dr. Rosen, a Morris Animal Foundation fellowship training grant recipient. "Managing threats to elephant health is important for conservation of this iconic species, as well as other wildlife."

Another important finding by Dr. Rosen's team was that seropositive status was linked to time in captivity. The working elephants that were in captivity the shortest period of time were most likely to be seropositive, a marker of exposure.

This is the first study to assess tuberculosis seroprevalence and risk factors in working African elephants in their home range. Because of potential contact between these elephants and other wildlife, it is critical to understand transmission and other characteristics of this disease.

"The findings of the Colorado State University team provide critical pieces of information to help ensure both wild and working elephants are protected from the ravages of tuberculosis, a devastating disease in these animals," said Kelly Diehl, DVM MS, Senior Scientific Programs and Communications Adviser at Morris Animal Foundation. "In addition, the people who are interacting with these populations will better understand not only the risks for transmission, but how to better protect themselves."

This project is part of a large, comprehensive study by the Colorado State University team identifying risk factors for tuberculosis in African and Asian elephants housed in North American and African facilities. This new information will be used to design and implement prevention and control strategies to reduce tuberculosis infections in elephants and other species. Because of the importance of tuberculosis in animal health, Morris Animal Foundation funds a number of studies focusing on this disease in multiple species around the world from white-tailed deer in North America to badgers in Europe to lions in Africa.
-end-
About Morris Animal Foundation

Established in 1948, Morris Animal Foundation is dedicated to improving and protecting the health of animals through scientific innovation, education and inspiration. Our investment in research has yielded life-saving vaccines, new treatments for critical diseases, superior screening tests, and advanced diagnostic tools. We respond to emerging animal health threats that endanger entire species, and make new discoveries in basic animal biology to support applied research. With every study we fund - more than 2,600 to date - we strive to advance the science of veterinary medicine, honoring the founding principles of Dr. Mark L. Morris Sr., and benefitting animals worldwide.

Morris Animal Foundation

Related Tuberculosis Articles:

Old target, new mechanism for overcoming tuberculosis resistance
In strains of tuberculosis that have developed drug resistance mutations, researchers have identified a secondary pathway that can be activated to reinstate drug sensitivity.
Researchers use tiny 3-D spheres to combat tuberculosis
Researchers at the University of Southampton have developed a new 3-D system to study human infection in the laboratory.
How the tuberculosis vaccine may protect against other diseases
The tuberculosis vaccine is well known to help protect against other infectious diseases, as well as cancer, but the exact mechanisms have not been clear.
Tuberculosis bacteria find their ecological niche
An international team of researchers have isolated and analyzed genetically tuberculosis bacteria from several thousand patients from over a hundred countries.
Tuberculosis and HIV co-infection
The HIV virus increases the potency of the tuberculosis bacterium (Mtb) by affecting a central function of the immune system.
Scientists explain why Russian tuberculosis is the most infectious
Scientists conducted a large-scale analysis of the proteins and genomes of mycobacterium tuberculosis strains that are common in Russia and countries of the former Soviet Union and found features that provide a possible explanation for their epidemiological success.
Tuberculosis elimination at stake
New data released by the European Centre for Disease Prevention and Control and WHO/Europe show that an estimated 340,000 Europeans developed tuberculosis in 2014, corresponding to a rate of 37 cases per 100,000 population.
Curcumin may help overcome drug-resistant tuberculosis
New research indicates that curcumin -- a substance in turmeric that is best known as one of the main components of curry powder -- may help fight drug-resistant tuberculosis.
Stopping tuberculosis requires new strategy
Unless there is a major shift in the way the world fights tuberculosis -- from a reliance on biomedical solutions to an approach that combines biomedical interventions with social actions -- the epidemic and drug resistance will worsen, say researchers at Harvard T.H.
Tulane researchers working on new tuberculosis vaccine
Researchers at the Tulane National Primate Research Center are leading efforts to find a new vaccine for tuberculosis, one of the world's deadliest diseases.

Related Tuberculosis Reading:

Catching Breath: The Making and Unmaking of Tuberculosis (Bloomsbury Sigma)
by Kathryn Lougheed (Author)

Invincible Microbe: Tuberculosis and the Never-Ending Search for a Cure
by Jim Murphy (Author), Alison Blank (Author)

Tuberculosis and Nontuberculous Mycobacterial Infections
by David Schlossberg (Editor)

Discovering Tuberculosis: A Global History, 1900 to the Present
by Christian W. McMillen (Author)

The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost
by Frank Ryan (Author)

Handbook of Tuberculosis
by Jacques H. Grosset (Editor), Richard E. Chaisson (Editor)

Spitting Blood: The history of tuberculosis
by OUP Oxford

Million Dollar Man: Surviving Tuberculosis
by Royce L. Gaye (Author), Elle Gaye (Author), Elle Gaye (Photographer)

Tuberculosis and the Victorian Literary Imagination (Cambridge Studies in Nineteenth-Century Literature and Culture)
by Katherine Byrne (Author)

The White Plague: Tuberculosis, Man and Society: Tuberculosis, Man, and Society
by Rutgers University Press

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".